CalciMedica, Inc. Common Stock (CALC NASDAQ) stock market data APIs
$3.1712
0.08(2.5%)
as of September 17, 2025
Try our APIs with
free plan!
CalciMedica, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also develops Auxora for the treatment of acute ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory indications. The company is based in La Jolla, California.
Prev. Close
3.1712
Open
3.2465
High
3.3056
Low
3.103
52 wk Range
1.42-5.65
Market Cap
43 523 K
Shares Outstanding
13 972 K
EPS
-0.4
Beta
1.275
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with CalciMedica, Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CalciMedica, Inc. Common Stock data using free add-ons & libraries
Get CalciMedica, Inc. Common Stock Fundamental Data
CalciMedica, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -24 968 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: 7.12
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CalciMedica, Inc. Common Stock News
New
CalciMedica director Roberts buys $14,708 in company stock
Director Eric W. Roberts of CalciMedica, Inc. (NASDAQ:CALC) recently purchased 5,076 shares of common stock at a weighted average price of $2.8977, in a transaction valued at $14,708. The prices for t...
Hebbar, CalciMedica CMO, buys $16k in CALC stock
CalciMedica, Inc. (NASDAQ:CALC), a small-cap biotech company valued at $42 million, saw Chief Medical Officer Sudarshan Hebbar report purchasing shares of the company’s common stock in two transacti...
CalciMedica (CALC) officer Roberts buys $5,760 in shares
CalciMedica, Inc. NASDAQ:CALC) Chief Business Officer Eric W. Roberts reported purchasing 2,000 shares of common stock on July 18, 2025. The shares were bought at a price of $2.88, totaling $5,760. Th...
Calcimedica (CALC) CEO Leheny buys $6k in stock
CalciMedica, Inc. (NASDAQ:CALC) CEO Leheny A. Rachel reported purchasing 2,500 shares of common stock on July 14, 2025, at a price of $2.47 per share. The total value of the purchase was $6,175. The p...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
